Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Biblioteca Digital de Teses e Dissertações da UFRRJ |
Texto Completo: | https://tede.ufrrj.br/jspui/handle/jspui/2779 |
Resumo: | Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia resulting from insulin resistance and/or deficiency. It is a metabolic disorder with high healthcare impact worldwide because of its chronic complications and high mortality rate. Type II diabetic patients can control their glycemic levels with the use of hypoglycemic drugs. Glibenclamide is a potent oral hypoglycemic drug that has been used in the treatment of DM-II, however, it has low water solubility and slow dissolution rate. In this study, glibenclamide microparticles were produced by the antisolvent precipitation process using water as the antisolvent. The four-factor three-level orthogonal array design OA9(3)4 proposed by Genichi Taguchi was used to investigate the effect of the following four factors on particle size and morphology: glibenclamide solution concentration [mg.mL-1], antisolvent/solvent volume ratio [A/S], stirring intensity [rpm], and surfactant concentration [% wt/wt]. Crystallized glibenclamide particles were characterized by optical microscopy, X-ray diffraction, and Fourier Transform Infrared Spectroscopy; the dissolution rate was characterized by HPLC. The surfactant concentration had a significant effect on the mean particle diameters of crystallized glibenclamide, followed by drug solution concentration, antisolvent/solvent volume ratio and stirring intensity, and the smaller sizes were observed with 1,0 mg.mL-1, A/S 10, 1500 rpm and 0,002 % wt/wt. The results indicate that crystallinity and chemical structure were not changed, however, the morphology and dissolution rate were affected by the factors. The results in this study show that the antisolvent precipitation process is effective in the preparation of microparticles of poorly water-soluble drugs. These contributions could expand the potential for new therapeutic drugs with low dissolution rates. |
id |
UFRRJ-1_95fa8ee2d6656305e92e6596285956be |
---|---|
oai_identifier_str |
oai:localhost:jspui/2779 |
network_acronym_str |
UFRRJ-1 |
network_name_str |
Biblioteca Digital de Teses e Dissertações da UFRRJ |
repository_id_str |
|
spelling |
Coelho, Gerson Luiz Vieira376.071.627-04Coelho, Gerson Luiz VieiraMedronho, Ricardo de AndradeCal?ada, Lu?s Am?rico103.056.986-05http://lattes.cnpq.br/5668922585391362Costa, Camila Stefanne Dias2019-07-03T20:53:21Z2015-02-23COSTA, Camila Stefanne Dias. Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido. 2015. 70 f. Disserta??o (Mestrado em Engenharia Qu?mica). Instituto de Tecnologia, Departamento de Engenharia Qu?mica, Universidade Federal Rural do Rio de Janeiro, Serop?dica, 2015.https://tede.ufrrj.br/jspui/handle/jspui/2779Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia resulting from insulin resistance and/or deficiency. It is a metabolic disorder with high healthcare impact worldwide because of its chronic complications and high mortality rate. Type II diabetic patients can control their glycemic levels with the use of hypoglycemic drugs. Glibenclamide is a potent oral hypoglycemic drug that has been used in the treatment of DM-II, however, it has low water solubility and slow dissolution rate. In this study, glibenclamide microparticles were produced by the antisolvent precipitation process using water as the antisolvent. The four-factor three-level orthogonal array design OA9(3)4 proposed by Genichi Taguchi was used to investigate the effect of the following four factors on particle size and morphology: glibenclamide solution concentration [mg.mL-1], antisolvent/solvent volume ratio [A/S], stirring intensity [rpm], and surfactant concentration [% wt/wt]. Crystallized glibenclamide particles were characterized by optical microscopy, X-ray diffraction, and Fourier Transform Infrared Spectroscopy; the dissolution rate was characterized by HPLC. The surfactant concentration had a significant effect on the mean particle diameters of crystallized glibenclamide, followed by drug solution concentration, antisolvent/solvent volume ratio and stirring intensity, and the smaller sizes were observed with 1,0 mg.mL-1, A/S 10, 1500 rpm and 0,002 % wt/wt. The results indicate that crystallinity and chemical structure were not changed, however, the morphology and dissolution rate were affected by the factors. The results in this study show that the antisolvent precipitation process is effective in the preparation of microparticles of poorly water-soluble drugs. These contributions could expand the potential for new therapeutic drugs with low dissolution rates.Diabetes mellitus (DM) ? uma doen?a cr?nica caracterizada pela constante hiperglicemia sangu?nea resultante da resist?ncia e/ou defici?ncia na a??o da insulina. ? uma desordem metab?lica de grande impacto na sa?de mundial devido ? suas complica??es cr?nicas e alta taxa de mortalidade. Pacientes diagnosticados com o diabetes do tipo II podem controlar o n?vel glic?mico com o uso de hipoglicemiantes. A Glibenclamida ? um potente hipoglicemiante oral que tem sido utilizado no tratamento do DM-II, entretanto, possui baixa solubilidade aquosa e lenta taxa de dissolu??o. Neste estudo, micropart?culas de glibenclamida foram produzidas por processo de precipita??o com antissolvente l?quido usando ?gua como antissolvente. O design ortogonal OA9(3)4 proposto por Genichi Taguchi foi utilizado para investigar o efeito dos seguintes quatro fatores no tamanho e morfologia das part?culas: concentra??o da solu??o [mg.mL-1], raz?o de volume antissolvente/solvente [A/S], intensidade de agita??o [rpm] e concentra??o de aditivo [% m/m]. As part?culas de glibenclamida cristalizadas foram caracterizadas por microscopia ?tica, difra??o de raios-X e espectroscopia no infravermelho com Transformada de Fourier; a taxa de dissolu??o foi caracterizada por cromatografia l?quida de alta efici?ncia. A concentra??o de aditivo teve um significante efeito no di?metro m?dio das part?culas cristalizadas, seguida pela concentra??o da solu??o, raz?o de volume antissolvente/solvente e intensidade de agita??o, sendo que os menores di?metros foram obtidos quando os seguintes n?veis foram utilizados: 1,0 mg.mL-1, A/S 10, 1500 rpm e 0,002 % m/m. Os resultados neste estudo mostram que o processo de precipita??o com antissolvente ? efetivo na prepara??o de micropart?culas de drogas insuficientemente sol?veis em ?gua. Estas contribui??es poderiam expandir o potencial terap?utico de outras drogas de baixa solubilidade aquosa.Submitted by Jorge Silva (jorgelmsilva@ufrrj.br) on 2019-07-03T20:53:21Z No. of bitstreams: 1 2015 - Camila Stefanne Dias Costa.pdf: 2354534 bytes, checksum: 642d93d0ed7331950a12bc2e0e037a79 (MD5)Made available in DSpace on 2019-07-03T20:53:21Z (GMT). No. of bitstreams: 1 2015 - Camila Stefanne Dias Costa.pdf: 2354534 bytes, checksum: 642d93d0ed7331950a12bc2e0e037a79 (MD5) Previous issue date: 2015-02-23CAPESFAPERJapplication/pdfhttps://tede.ufrrj.br/retrieve/10141/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/16270/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/22564/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/28944/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/35296/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/41692/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/48094/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpghttps://tede.ufrrj.br/retrieve/54546/2015%20-%20Camila%20Stefanne%20Dias%20Costa.pdf.jpgporUniversidade Federal Rural do Rio de JaneiroPrograma de P?s-Gradua??o em Engenharia Qu?micaUFRRJBrasilInstituto de Tecnologiaglibenclamidaprecipita??o com antissolventecaracteriza??otaxa de dissolu??oglibenclamideantisolvent precipitationcharacterizationdissolution rateEngenharia Qu?micaCristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quidoCrystallization of the pharmaceutically active agent glibenclamide by the aqueous antisolvent precipitation processinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFRRJinstname:Universidade Federal Rural do Rio de Janeiro (UFRRJ)instacron:UFRRJTHUMBNAIL2015 - Camila Stefanne Dias Costa.pdf.jpg2015 - Camila Stefanne Dias Costa.pdf.jpgimage/jpeg3835http://localhost:8080/tede/bitstream/jspui/2779/18/2015+-+Camila+Stefanne+Dias+Costa.pdf.jpg34aa99b429e3554565886af0a861930bMD518TEXT2015 - Camila Stefanne Dias Costa.pdf.txt2015 - Camila Stefanne Dias Costa.pdf.txttext/plain148032http://localhost:8080/tede/bitstream/jspui/2779/17/2015+-+Camila+Stefanne+Dias+Costa.pdf.txt7941bc72d9c10f49ef7cdae41e728b06MD517ORIGINAL2015 - Camila Stefanne Dias Costa.pdf2015 - Camila Stefanne Dias Costa.pdfapplication/pdf2354534http://localhost:8080/tede/bitstream/jspui/2779/2/2015+-+Camila+Stefanne+Dias+Costa.pdf642d93d0ed7331950a12bc2e0e037a79MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82089http://localhost:8080/tede/bitstream/jspui/2779/1/license.txt7b5ba3d2445355f386edab96125d42b7MD51jspui/27792023-02-15 15:41:03.77oai:localhost: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Biblioteca Digital de Teses e Dissertaçõeshttps://tede.ufrrj.br/PUBhttps://tede.ufrrj.br/oai/requestbibliot@ufrrj.br||bibliot@ufrrj.bropendoar:2023-02-15T17:41:03Biblioteca Digital de Teses e Dissertações da UFRRJ - Universidade Federal Rural do Rio de Janeiro (UFRRJ)false |
dc.title.por.fl_str_mv |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido |
dc.title.alternative.eng.fl_str_mv |
Crystallization of the pharmaceutically active agent glibenclamide by the aqueous antisolvent precipitation process |
title |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido |
spellingShingle |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido Costa, Camila Stefanne Dias glibenclamida precipita??o com antissolvente caracteriza??o taxa de dissolu??o glibenclamide antisolvent precipitation characterization dissolution rate Engenharia Qu?mica |
title_short |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido |
title_full |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido |
title_fullStr |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido |
title_full_unstemmed |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido |
title_sort |
Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido |
author |
Costa, Camila Stefanne Dias |
author_facet |
Costa, Camila Stefanne Dias |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Coelho, Gerson Luiz Vieira |
dc.contributor.advisor1ID.fl_str_mv |
376.071.627-04 |
dc.contributor.referee1.fl_str_mv |
Coelho, Gerson Luiz Vieira |
dc.contributor.referee2.fl_str_mv |
Medronho, Ricardo de Andrade |
dc.contributor.referee3.fl_str_mv |
Cal?ada, Lu?s Am?rico |
dc.contributor.authorID.fl_str_mv |
103.056.986-05 |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/5668922585391362 |
dc.contributor.author.fl_str_mv |
Costa, Camila Stefanne Dias |
contributor_str_mv |
Coelho, Gerson Luiz Vieira Coelho, Gerson Luiz Vieira Medronho, Ricardo de Andrade Cal?ada, Lu?s Am?rico |
dc.subject.por.fl_str_mv |
glibenclamida precipita??o com antissolvente caracteriza??o |
topic |
glibenclamida precipita??o com antissolvente caracteriza??o taxa de dissolu??o glibenclamide antisolvent precipitation characterization dissolution rate Engenharia Qu?mica |
dc.subject.eng.fl_str_mv |
taxa de dissolu??o glibenclamide antisolvent precipitation characterization dissolution rate |
dc.subject.cnpq.fl_str_mv |
Engenharia Qu?mica |
description |
Diabetes mellitus (DM) is a chronic disease characterized by persistent hyperglycemia resulting from insulin resistance and/or deficiency. It is a metabolic disorder with high healthcare impact worldwide because of its chronic complications and high mortality rate. Type II diabetic patients can control their glycemic levels with the use of hypoglycemic drugs. Glibenclamide is a potent oral hypoglycemic drug that has been used in the treatment of DM-II, however, it has low water solubility and slow dissolution rate. In this study, glibenclamide microparticles were produced by the antisolvent precipitation process using water as the antisolvent. The four-factor three-level orthogonal array design OA9(3)4 proposed by Genichi Taguchi was used to investigate the effect of the following four factors on particle size and morphology: glibenclamide solution concentration [mg.mL-1], antisolvent/solvent volume ratio [A/S], stirring intensity [rpm], and surfactant concentration [% wt/wt]. Crystallized glibenclamide particles were characterized by optical microscopy, X-ray diffraction, and Fourier Transform Infrared Spectroscopy; the dissolution rate was characterized by HPLC. The surfactant concentration had a significant effect on the mean particle diameters of crystallized glibenclamide, followed by drug solution concentration, antisolvent/solvent volume ratio and stirring intensity, and the smaller sizes were observed with 1,0 mg.mL-1, A/S 10, 1500 rpm and 0,002 % wt/wt. The results indicate that crystallinity and chemical structure were not changed, however, the morphology and dissolution rate were affected by the factors. The results in this study show that the antisolvent precipitation process is effective in the preparation of microparticles of poorly water-soluble drugs. These contributions could expand the potential for new therapeutic drugs with low dissolution rates. |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015-02-23 |
dc.date.accessioned.fl_str_mv |
2019-07-03T20:53:21Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
COSTA, Camila Stefanne Dias. Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido. 2015. 70 f. Disserta??o (Mestrado em Engenharia Qu?mica). Instituto de Tecnologia, Departamento de Engenharia Qu?mica, Universidade Federal Rural do Rio de Janeiro, Serop?dica, 2015. |
dc.identifier.uri.fl_str_mv |
https://tede.ufrrj.br/jspui/handle/jspui/2779 |
identifier_str_mv |
COSTA, Camila Stefanne Dias. Cristaliza??o do princ?pio ativo farmac?utico glibenclamida por processo de precipita??o com antissolvente l?quido. 2015. 70 f. Disserta??o (Mestrado em Engenharia Qu?mica). Instituto de Tecnologia, Departamento de Engenharia Qu?mica, Universidade Federal Rural do Rio de Janeiro, Serop?dica, 2015. |
url |
https://tede.ufrrj.br/jspui/handle/jspui/2779 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal Rural do Rio de Janeiro |
dc.publisher.program.fl_str_mv |
Programa de P?s-Gradua??o em Engenharia Qu?mica |
dc.publisher.initials.fl_str_mv |
UFRRJ |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
Instituto de Tecnologia |
publisher.none.fl_str_mv |
Universidade Federal Rural do Rio de Janeiro |
dc.source.none.fl_str_mv |
reponame:Biblioteca Digital de Teses e Dissertações da UFRRJ instname:Universidade Federal Rural do Rio de Janeiro (UFRRJ) instacron:UFRRJ |
instname_str |
Universidade Federal Rural do Rio de Janeiro (UFRRJ) |
instacron_str |
UFRRJ |
institution |
UFRRJ |
reponame_str |
Biblioteca Digital de Teses e Dissertações da UFRRJ |
collection |
Biblioteca Digital de Teses e Dissertações da UFRRJ |
bitstream.url.fl_str_mv |
http://localhost:8080/tede/bitstream/jspui/2779/18/2015+-+Camila+Stefanne+Dias+Costa.pdf.jpg http://localhost:8080/tede/bitstream/jspui/2779/17/2015+-+Camila+Stefanne+Dias+Costa.pdf.txt http://localhost:8080/tede/bitstream/jspui/2779/2/2015+-+Camila+Stefanne+Dias+Costa.pdf http://localhost:8080/tede/bitstream/jspui/2779/1/license.txt |
bitstream.checksum.fl_str_mv |
34aa99b429e3554565886af0a861930b 7941bc72d9c10f49ef7cdae41e728b06 642d93d0ed7331950a12bc2e0e037a79 7b5ba3d2445355f386edab96125d42b7 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Biblioteca Digital de Teses e Dissertações da UFRRJ - Universidade Federal Rural do Rio de Janeiro (UFRRJ) |
repository.mail.fl_str_mv |
bibliot@ufrrj.br||bibliot@ufrrj.br |
_version_ |
1800313489416257536 |